| 1 |
28820457 | Role of CYP2C9, CYP2C19 and EPHX Polymorphism in the Pharmacokinetic of Phenytoin: A Study on Uruguayan Caucasian Subjects. | 2017 Aug 18 |
1 |
| 2 |
19952982 | Maternal EPHX1 polymorphisms and risk of phenytoin-induced congenital malformations. | 2010 Jan |
4 |
| 3 |
27713373 | Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy. | 2010 Aug 20 |
1 |
| 4 |
19364907 | The expression of human microsomal epoxide hydrolase is predominantly driven by a genetically polymorphic far upstream promoter. | 2009 Jul |
2 |
| 5 |
11471167 | Analysis of the EPHX1 113 polymorphism and GSTM1 homozygous null polymorphism and oral clefting associated with maternal smoking. | 2001 Jul 22 |
1 |
| 6 |
9406998 | Tissue-specific expression and alternative splicing of human microsomal epoxide hydrolase. | 1997 Nov |
1 |
| 7 |
1683079 | Differences in phenytoin biotransformation and susceptibility to congenital malformations: a review. | 1991 Sep |
1 |